Average Co-Inventor Count = 6.45
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (19 from 2,405 patents)
2. Sarcode Bioscience Inc. (10 from 25 patents)
3. Lycera Corporation (8 from 36 patents)
4. University of Pittsburgh (4 from 1,860 patents)
5. Sunesis Pharmaceuticals, Inc. (4 from 63 patents)
6. Sarcode Corporation (4 from 4 patents)
7. Abbott Laboratories Corporation (3 from 4,177 patents)
8. Merck Sharp + Dohme B.v. (3 from 55 patents)
9. Biogen Idec Ma Inc. (1 from 216 patents)
44 patents:
1. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
2. 10584121 - Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof
3. 10377768 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
4. 10221142 - Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
5. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
6. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
7. 10124000 - Modulators of cellular adhesion
8. 9884043 - RORgammaT inhibitors
9. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
10. 9783511 - Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
11. 9745265 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
12. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
13. 9663522 - 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof
14. 9657033 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
15. 9603838 - RORgammaT inhibitors